Dear CAMRT Members,
This email is intended to provide you with an update on the message sent earlier this week with regard to the recent production issues at the HFR Reactor in the Netherlands.
The CAMRT has been in touch with contacts at AIPES and the OECD, as well as at Health Canada, and has confirmed that:
- The HFR Reactor returned to operation on October 31st.
- We can expect some global supply shortages next week due to the gap in production but supply levels are predicted to return to normal soon after.
Through the AIPES ERT, producers and suppliers are working collaboratively to mitigate the situation, attention to efficient usage of medical isotopes is highly recommended at this time. For your reference, a link to the Supply Management Application to Rank Uses of Technetium-99m (The “S.M.A.R.T.” Tool) is noted here https://www.cadth.ca/SMART-Tool.
CAMRT, with its partners in the Government of Canada is monitoring the situation closely. We are interested to hear if you are experiencing any disruption to your own local supply of medical isotopes. Please send these updates, or any other feedback to Christopher Topham, Director of Advocacy and Communications at email@example.com.